<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03798834</url>
  </required_header>
  <id_info>
    <org_study_id>R/17.07.111</org_study_id>
    <nct_id>NCT03798834</nct_id>
  </id_info>
  <brief_title>Fascia Iliaca Block for Anesthesia in Lower Limb Thromboembolectomy</brief_title>
  <official_title>Fascia Iliaca Block as an Anesthetic Technique for Thromboembolectomy of Chronic Lower Limb Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The fascia iliaca block (FIB) is an anterior approach to block the lumbar plexus. It&#xD;
      disturbed mainly to the anterior region of the thigh by blocking the femoral nerve (LFC) and&#xD;
      the lateral femoral cutaneous nerve. Moreover, FIB may possibly be extended to the obturator,&#xD;
      ilioinguinal, genitofemoral, lateral cutaneous nerve of the thigh and over the psoas muscle&#xD;
      but, rarely reaches the lumbar plexus.&#xD;
&#xD;
      The fascia iliaca compartment could be detected by bony landmarks palpation and the loss of&#xD;
      resistance technique. Feeling two tactile ''pops'' due to loss of resistance occurred during&#xD;
      the needle passage through the fascia lata and the fascia iliaca. Ultrasound (US) guidance of&#xD;
      FIB will increase the success rate and the efficacy of sensory blockade by decreasing the&#xD;
      needed local anesthetic amount.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was conducted to demonstrate the success incidence (to evaluate the efficacy) of&#xD;
      preoperative 0.25% bupivacaine FIB as a sole anesthetic technique in thromboembolectomy of&#xD;
      unilateral chronic lower limb ischemia compared to neuraxial anesthesiaas a primary goal.&#xD;
      Intraoperative hemodynamics variation, postoperative pain score, total analgesic rescue&#xD;
      requests and the total amount of systemic rescue analgesia used in the first postoperative&#xD;
      day in addition to any detected postoperative complications were secondary goals. The&#xD;
      hypothesis is that; FIB will provide adequate anesthesia as neuraxial anesthesia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 17, 2018</start_date>
  <completion_date type="Actual">April 15, 2019</completion_date>
  <primary_completion_date type="Actual">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The proportion of the patients who did not require conversion to general anesthesia</measure>
    <time_frame>for 30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>For 24 hours after the intervention</time_frame>
    <description>The post-operative pain will recorded using 10-point Visual Analog Scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>For 6 hours after the intervention</time_frame>
    <description>changes in Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean arterial pressure (MAP</measure>
    <time_frame>For 6 hours after the intervention</time_frame>
    <description>changes in mean arterial pressure (MAP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypotension</measure>
    <time_frame>For 24 hours from the block</time_frame>
    <description>Incidents of hypotension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any observed adverse effects</measure>
    <time_frame>over the 24 hours postoperative</time_frame>
    <description>ny adverse effects will be observed over the 24 hours postoperative for local skin hematoma ,sensory deficits or local bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bradycardia</measure>
    <time_frame>For 24 hours from the block</time_frame>
    <description>Incidents if bradycardia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Chronic Lower Limb Ischemia</condition>
  <arm_group>
    <arm_group_label>Fascia iliaca block (FIB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ultrasound-guided Fascia iliaca block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spinal anesthesia</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Spinal anaesthesia using 2 ml hyperbaric bupivacaine 0.5%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fascia iliaca block (FIB)</intervention_name>
    <description>ultrasound-guided Fascia iliaca block</description>
    <arm_group_label>Fascia iliaca block (FIB)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spinal anesthesia</intervention_name>
    <description>Spinal anaesthesia using 2 ml hyperbaric bupivacaine 0.5%</description>
    <arm_group_label>Spinal anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA physical status I or II.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with previous same lower limb surgery&#xD;
&#xD;
          -  Neuromuscular disease&#xD;
&#xD;
          -  Severe cardiovascular disease&#xD;
&#xD;
          -  Any contraindications to regional anesthesia&#xD;
&#xD;
          -  patient refusal&#xD;
&#xD;
          -  coagulation abnormality&#xD;
&#xD;
          -  Known allergy to local anesthetics&#xD;
&#xD;
          -  Infection at the injection site&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reem A Elsharkawy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Lecturer of Anesthesia and Surgical Intensive Care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura University</name>
      <address>
        <city>Mansourah</city>
        <state>DK</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>January 8, 2019</study_first_submitted>
  <study_first_submitted_qc>January 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2019</study_first_posted>
  <last_update_submitted>September 19, 2020</last_update_submitted>
  <last_update_submitted_qc>September 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

